Radiation after surgery may keep rare adrenal cancer at bay
NCT ID NCT07141147
First seen Jun 26, 2026 ยท Last updated Jun 26, 2026
Summary
This study looks at whether giving radiation therapy after surgery can help prevent high-risk adrenocortical carcinoma from coming back. Fifty-eight patients who had their tumor completely removed will be randomly assigned to either receive radiation or just be monitored. The main goal is to see if radiation improves the chance of staying cancer-free for three years.
What this could mean
Our plain-language read of the trial. This is informational only โ not medical advice or a prediction.
- Active substance
- radiation therapy
- What this could lead to
- If successful, this could show that adding radiotherapy after surgery helps prevent cancer from coming back in patients with high-risk adrenocortical carcinoma.
- What could go wrong
- This is a small early-stage trial with only 58 patients, so results may not apply broadly. Radiotherapy can cause side effects like damage to nearby organs.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for HIGH-RISK LOCALIZED ADRENOCORTICAL CARCINOMA are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Cancer Center, Sun Yat-sen University
Guangzhou, Guangdong, 510060, China
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Can a simple supplement soothe Radiation-Damaged rectums?
- Can imaging reveal how radiation shapes marrow recovery?
- Can a targeted drug combo boost chemoradiation in EGFR-Positive lung cancer?
- Can a video call replace a clinic visit for cancer patients on radiotherapy?
- Breast reconstruction after mastectomy: which approach leads to happier patients?
- Two-Drug combo aims to wipe out rectal cancer before surgery